Concert Pharmaceuticals Inc.

05/23/2022 | Press release | Distributed by Public on 05/23/2022 05:06

Concert Pharmaceuticals Reports Positive Topline Results for First CTP-543 Phase 3 Clinical Trial in Alopecia Areata